Bausch Health Companies Inc. Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests
Bausch Health Companies Inc. (BHC) reported Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests of $18.00 million for the 12-month period ending 2018-12-31, per its 8-K filed 2021-05-04.
Discontinued › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:MinorityInterestDecreaseFromRedemptions · last filed 2021-05-04
- Bausch Health Companies Inc. noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2014-12-31 was -$300.00K.
- Bausch Health Companies Inc. noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2014-09-30 was $0.00.
- Bausch Health Companies Inc. noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2014-06-30 was $0.00.
- Bausch Health Companies Inc. noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2014-03-31 was $3.30M.
- Bausch Health Companies Inc. noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2017 was $9.00M.
- Bausch Health Companies Inc. noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2014 was $3.00M.
- Bausch Health Companies Inc. noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2011 was $58.32M.
| Period end | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 3 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 6 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 9 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 12 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | $18.00M 8-K · filed 2021-05-04 | ||||
| 2017-12-31 | $9.00M 10-K · filed 2020-02-19 | ||||
| 2014-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$300.00K derived: sum of 2 quarters · filed 2017-03-01 | -$300.00K derived: sum of 3 quarters · filed 2017-03-01 | $3.00M 10-K · filed 2017-03-01 | $3.30M 10-K · filed 2015-02-25 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-26 | $0.00 derived: sum of 2 quarters · filed 2015-10-26 | $3.30M 10-Q · filed 2015-10-26 | ||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28 | $3.30M 10-Q · filed 2015-07-28 | |||
| 2014-03-31 | $3.30M 10-Q · filed 2015-04-30 | ||||
| 2011-12-31 | $24.34M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $58.32M 10-K · filed 2014-02-28 | |||
| 2011-09-30 | $33.98M 10-Q · filed 2012-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |